128 related articles for article (PubMed ID: 8258707)
21. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
22. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
[TBL] [Abstract][Full Text] [Related]
23. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
24. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
25. T cell tolerance and autoimmunity.
Abbas AK; Lohr J; Knoechel B; Nagabhushanam V
Autoimmun Rev; 2004 Nov; 3(7-8):471-5. PubMed ID: 15546793
[TBL] [Abstract][Full Text] [Related]
26. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
27. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
Guerder S; Eynon EE; Flavell RA
J Immunol; 1998 Sep; 161(5):2128-40. PubMed ID: 9725204
[TBL] [Abstract][Full Text] [Related]
28. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma.
Vilchez RA; Lopez-Terrada D; Middleton JR; Finch CJ; Killen DE; Zanwar P; Jorgensen JL; Butel JS
Virology; 2005 Nov; 342(1):38-46. PubMed ID: 16122775
[TBL] [Abstract][Full Text] [Related]
29. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
30. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene.
Tzeng YJ; Guhl E; Graessmann M; Graessmann A
Oncogene; 1993 Jul; 8(7):1965-71. PubMed ID: 8390039
[TBL] [Abstract][Full Text] [Related]
32. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
[TBL] [Abstract][Full Text] [Related]
33. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
Bright RK; Beames B; Shearer MH; Kennedy RC
Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
[TBL] [Abstract][Full Text] [Related]
34. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
35. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
36. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
Nayernia K; Samani AA; Klaproth S; Engel W
Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
[TBL] [Abstract][Full Text] [Related]
37. Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.
Romieu R; Baratin M; Kayibanda M; Lacabanne V; Ziol M; Guillet JG; Viguier M
J Immunol; 1998 Nov; 161(10):5133-7. PubMed ID: 9820481
[TBL] [Abstract][Full Text] [Related]
38. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
39. Does interleukin-2 abrogate peripheral immunologic self-tolerance in vivo?
Allison J; Heath W; Miller JF
Semin Immunol; 1992 Jun; 4(3):181-5. PubMed ID: 1627789
[TBL] [Abstract][Full Text] [Related]
40. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
